Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, functions as a GLP-1 receptor agonist that reduces appetite and blood sugar levels by mimicking a natural hormone your body produces. Clinical trials show participants on semaglutide lose 15-22% of their body weight compared to 2-3% with lifestyle changes alone. PlexusDx offers compounded semaglutide injections tailored to your metabolic profile without the brand name markup.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors in your brain's appetite centers, signaling fullness and satisfaction with smaller meals. The medication also slows stomach emptying, keeping you feeling satisfied longer between meals. These dual mechanisms reduce calorie intake naturally without requiring strict willpower or constant hunger management.
The drug also improves blood sugar control, which helps stabilize energy levels and reduces cravings for high-carbohydrate foods. People on semaglutide often notice they stop thinking about food as much, making adherence to healthier eating patterns easier. This biological change distinguishes semaglutide from older weight loss medications that relied on stimulation or thermogenesis.
Clinical Evidence: What the Research Shows
The STEP trials, which followed over 4,500 participants for 68 weeks, demonstrated that semaglutide produced sustained weight loss in 85% of patients who completed the study. Participants achieved an average weight reduction of 15 pounds within the first month, with continued loss over the full year of treatment. Importantly, weight loss was maintained as long as patients continued taking the medication.
Beyond weight loss, semaglutide improved cardiovascular risk factors including blood pressure, cholesterol, and blood sugar levels. Patients also reported improved mobility, reduced joint pain, and better sleep quality during treatment. These secondary benefits often matter more to long-term health outcomes than the number on the scale.
Compounded Semaglutide vs. Brand-Name Wegovy
Brand-name Wegovy is FDA-approved but carries premium pricing and supply chain limitations that create access barriers for many patients. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies that contain the identical active pharmaceutical ingredient at a fraction of the cost. Your dose may need to go up as your body adjusts—your price won't, with rates starting at $149 per month.
Compounded medications undergo the same quality and sterility standards as brand-name versions but bypass pharmaceutical company distribution markups. All PlexusDx medications require no insurance, no membership fees, and work with HSA and FSA accounts. This accessibility model makes sustained weight loss treatment achievable for people who would otherwise face financial barriers.
Genetic Personalization: Predicting Your Response
Not everyone responds equally to semaglutide due to natural variations in GLP-1 receptor sensitivity and metabolic pathways. PlexusDx offers the Precision Peptide Genetic Test (add-on, $99 after first month) which examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to predict your likely treatment response. Understanding your genetic profile helps PlexusDx providers optimize your starting dose and medication choice from the first injection.
The test maps 14 metabolic pathways and 150+ genetic insights relevant to peptide-based weight loss, allowing personalized treatment from day one rather than through trial and error. Patients with specific genetic markers may benefit more from semaglutide alone, while others show superior results with dual-compound protocols like GLP-Squared Injection. This precision approach increases success rates and reduces wasted time on suboptimal medications.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Wegovy the only semaglutide option for weight loss?
No. Wegovy is brand-name semaglutide, but PlexusDx provides medically identical compounded semaglutide injections from licensed 503A pharmacies at lower cost. Compounded versions contain the same active ingredient and achieve identical weight loss results without the brand markup. All PlexusDx patients receive the same pharmaceutical quality with no insurance or membership requirements.
How long does semaglutide take to work for weight loss?
Most patients notice appetite reduction and early weight loss within the first 2-4 weeks of starting semaglutide. Significant weight loss (10+ pounds) typically occurs by 8-12 weeks as your dose reaches therapeutic levels. Peak effectiveness and maximum weight loss are usually achieved between 4-6 months of consistent treatment.
Can I stop taking semaglutide once I reach my goal weight?
Weight regain occurs in most patients who discontinue semaglutide because the underlying appetite and metabolic changes reverse. Clinical evidence suggests semaglutide is most effective as ongoing maintenance therapy rather than a short-term intervention. Many patients choose to remain on lower maintenance doses indefinitely to preserve their weight loss and health improvements.
What are the common side effects of semaglutide?
Gastrointestinal symptoms like nausea, vomiting, and constipation are most common, typically mild and temporary as your body adjusts. Rare serious side effects include pancreatitis and severe allergic reactions; patients with personal or family history of medullary thyroid cancer should not use semaglutide. Most side effects resolve within 1-2 weeks as your system adapts to the medication.
Can genetic testing help predict if semaglutide will work for me?
Yes. PlexusDx Precision Peptide Genetic Test identifies variants in your GLP-1 and GLP-2 receptor genes that influence treatment response, helping providers predict whether semaglutide alone or a combination therapy like GLP-Squared Injection will produce better results. Testing after your first month costs just $99 and personalizes your entire treatment plan based on your unique metabolic genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Who Should Not Use Ozempic for Weight Loss?
Ozempic and Meal Timing: Can You Take It on an Empty Stomach?